Search research articles
Contact Us
Filters
Showing results (81-90 of 139) with videos related to
Page
of 14
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 1, 2020
Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver
Clémence M Canivet, Stéphanie Bonnafous, Déborah Rousseau, et al.
Surgical Endoscopy
|
November 8, 2013
Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots
Anne-Sophie Schneck, Antonio Iannelli, Stéphanie Patouraux, et al.
Biomedicines
|
May 27, 2026
Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis
Xavier Adhoute, Constance Chailloux, Feng Xia, et al.
Obesity Surgery
|
January 21, 2016
Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients
Rodolphe Anty, Audrey Hastier, Clémence M Canivet, et al.
World Journal of Clinical Cases
|
July 5, 2021
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results
Xavier Adhoute, Edouard Larrey, Rodolphe Anty, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 17, 2015
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study
Jean Marie Péron, Florence Abravanel, Maeva Guillaume, et al.
Biomedicines
|
July 27, 2022
Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver Transplantation
Audrey Laurain, Isabelle Rubera, Micheline Razzouk-Cadet, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
August 19, 2021
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
Carmelo Luci, Elodie Vieira, Manon Bourinet, et al.
World Journal of Gastrointestinal Oncology
|
September 26, 2022
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
Xavier Adhoute, Marie De Matharel, Laurent Mineur, et al.
Chinese Clinical Oncology
|
December 22, 2025
Nonsurgical hepatocellular carcinoma treated with selective internal radiation therapy and personalized dosimetry: real-life data from French centers
Louis Carmarans, Claude Somma, Victoria Ramdour, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 139) with videos related to
Sort By:
Page
of 14
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
February 1, 2020
Hepatic FNDC5 is a potential local protective factor against Non-Alcoholic Fatty Liver
Clémence M Canivet, Stéphanie Bonnafous, Déborah Rousseau, et al.
Surgical Endoscopy
|
November 8, 2013
Effects of sleeve gastrectomy in high fat diet-induced obese mice: respective role of reduced caloric intake, white adipose tissue inflammation and changes in adipose tissue and ectopic fat depots
Anne-Sophie Schneck, Antonio Iannelli, Stéphanie Patouraux, et al.
Biomedicines
|
May 27, 2026
Hepatocellular Carcinoma Treatment with Immune Checkpoint Inhibitors: RECA and CRAFITY Scores Reveal Distinct Clinical Courses and Highlight the Role of Systemic Inflammation in Prognosis
Xavier Adhoute, Constance Chailloux, Feng Xia, et al.
Obesity Surgery
|
January 21, 2016
Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients
Rodolphe Anty, Audrey Hastier, Clémence M Canivet, et al.
World Journal of Clinical Cases
|
July 5, 2021
Expected outcomes and patients' selection before chemoembolization-"Six-and-Twelve or Pre-TACE-Predict" scores may help clinicians: Real-life French cohorts results
Xavier Adhoute, Edouard Larrey, Rodolphe Anty, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 17, 2015
Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study
Jean Marie Péron, Florence Abravanel, Maeva Guillaume, et al.
Biomedicines
|
July 27, 2022
Arterial Calcifications in Patients with Liver Cirrhosis Are Linked to Hepatic Deficiency of Pyrophosphate Production Restored by Liver Transplantation
Audrey Laurain, Isabelle Rubera, Micheline Razzouk-Cadet, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
August 19, 2021
SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis
Carmelo Luci, Elodie Vieira, Manon Bourinet, et al.
World Journal of Gastrointestinal Oncology
|
September 26, 2022
Second-line therapy for advanced hepatocellular carcinoma with regorafenib or cabozantinib: Multicenter French clinical experience in real-life after matching
Xavier Adhoute, Marie De Matharel, Laurent Mineur, et al.
Chinese Clinical Oncology
|
December 22, 2025
Nonsurgical hepatocellular carcinoma treated with selective internal radiation therapy and personalized dosimetry: real-life data from French centers
Louis Carmarans, Claude Somma, Victoria Ramdour, et al.
Page
of 14